Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ted White Insider Profile
4 Followers
Ted White, President & CEO, Director at Verrica Pharmaceuticals, holds 215.97K shares in Verrica Pharmaceuticals (Ticker: VRCA).
Ted White Verrica Pharmaceuticals (VRCA)President & CEO, Director
Verrica Pharmaceuticals (VRCA)
President & CEO, Director
Ranked #50,045 out of 100,202 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-0.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Ted White holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 05, 2022 - Jul 05, 2023
Return:+136.80%
The most profitable trade made by Ted White
Ted White's Trading History
List of latest transactions for each holding click on a transaction to see Ted White's performance on stock
You May Also Like
Ted White insider profile FAQ
What is the percentage of profitable transactions made by Ted White?
The percentage of profitable transactions made by Ted White is 38%.
What is the average return per transaction made by Ted White?
The average return per transaction made by Ted White is -0.20%.
What stocks does Ted White hold?
Ted White holds: VRCA stocks.
What was Ted White’s latest transaction?
Ted White latest transaction was an Uninformative Sell of $88.64K.
What was Ted White's most profitable transaction?
Ted White’s most profitable transaction was an Informative Buy of VRCA stock on July 5, 2022. The return on the trade was 136.80%.
What is Ted White's role in Verrica Pharmaceuticals?
Ted White's role in Verrica Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.